Cancer Family
Hematopoietic and Lymphatic System Neoplasm
CI-CAN-00000022Explore in graph →
Non-malignant4,305 active trials98 approved drugs1,010 evidence items
- NCIt
- C35813
Loading cancer entity…
Cancer Family
CI-CAN-00000022Explore in graph →
Clinical trials
18,823 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02585947 | To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma | unknown | Phase 4 | 90 | Seoul National University HospitalOTHER | 1 | Dec 21, 2016 | clinicaltrials |
| NCT02996617 | PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia | unknown | Phase 4 | 240 | Shandong Provincial HospitalOTHER_GOV | 1 | Dec 19, 2016 | clinicaltrials |
| NCT02992834 | Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma | unknown | Phase 4 | 10 | jiangjingtingOTHER | 1 | Dec 14, 2016 | clinicaltrials |
| NCT02938741 | ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors | unknown | Phase 4 | 130 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 25, 2016 | clinicaltrials |
| NCT02929615 | Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors | unknown | Phase 4 | 50 | Peking UniversityOTHER | 1 | Oct 12, 2016 | clinicaltrials |
| NCT02894645 | Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study | unknown | Phase 4 | 500 | National University Hospital, SingaporeOTHER | 2 | Sep 30, 2016 | clinicaltrials |
| NCT02027064 | Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT | unknown | Phase 4 | 40 | Peking University People's HospitalOTHER | 1 | Sep 29, 2016 | clinicaltrials |
| NCT02905916 | The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy | unknown | Phase 4 | 217 | Peking UniversityOTHER | 1 | Sep 19, 2016 | clinicaltrials |
| NCT02905942 | PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation | unknown | Phase 4 | 96 | Peking UniversityOTHER | 1 | Sep 19, 2016 | clinicaltrials |
| NCT02784561 | Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation | unknown | Phase 4 | 80 | Chinese PLA General HospitalOTHER | 0 | May 27, 2016 | clinicaltrials |
| NCT01949818 | Treatment of Diffuse Large B Cell Lymphoma | unknown | Phase 4 | 120 | Mingzhi ZhangOTHER | 1 | Dec 30, 2015 | clinicaltrials |
| NCT01873807 | HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALL(HITA) | unknown | Phase 4 | 100 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT01960192 | Treatment of Primary CNS Lymphoma(FVD) | unknown | Phase 4 | 50 | Mingzhi ZhangOTHER | 1 | Jul 21, 2015 | clinicaltrials |
| NCT01501136 | Treatment of Natural Killer/T Cell Lymphoma-I/II(CTTNKTL-I/II) | unknown | Phase 4 | 200 | Mingzhi ZhangOTHER | 1 | Jul 17, 2015 | clinicaltrials |
| NCT01501149 | Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ(CTTNKTL-Ⅲ/Ⅳ) | unknown | Phase 4 | 80 | Mingzhi ZhangOTHER | 1 | Jul 17, 2015 | clinicaltrials |
| NCT02389920 | Multicenter, PhaseⅣ, Open Label Trial of Nilotinib in Adult Patients Diagnosed Philadelphia Chromosome Positive(Ph+) Chronic Myeloid Leukemia in CP/AP Intolerant to Dasatinib | unknown | Phase 4 | 40 | Samsung Medical CenterOTHER | 0 | Mar 17, 2015 | clinicaltrials |
| NCT02347878 | Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH) | unknown | Phase 4 | 85 | Sun Yat-sen UniversityOTHER | 1 | Jan 27, 2015 | clinicaltrials |
| NCT02317159 | Efficacy and Safety of Imatinib Mesylate as First-line Treatment for the Patients With Chronic Phase of Chronic Myeloid Leukemia | unknown | Phase 4 | 90 | CttqINDUSTRY | 0 | Dec 15, 2014 | clinicaltrials |
| NCT02277847 | Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia | unknown | Phase 4 | 400 | Guangdong Provincial People's HospitalOTHER | 0 | Oct 29, 2014 | clinicaltrials |
| NCT01587430 | 3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia | unknown | Phase 4 | 245 | National Research Center for Hematology, RussiaNETWORK | 1 | Apr 7, 2014 | clinicaltrials |
| NCT02024308 | AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy | unknown | Phase 4 | 62 | Changhai HospitalOTHER | 1 | Dec 31, 2013 | clinicaltrials |
| NCT01990807 | Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia | unknown | Phase 4 | 20 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 21, 2013 | clinicaltrials |
| NCT01901666 | Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission | unknown | Phase 4 | 20 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Jul 17, 2013 | clinicaltrials |
| NCT01868828 | A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma | unknown | Phase 4 | 50 | Peking University People's HospitalOTHER | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00180128 | AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia | unknown | Phase 4 | 80 | Technische Universität DresdenOTHER | 1 | Jul 11, 2011 | clinicaltrials |
| NCT01339988 | Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT) | unknown | Phase 4 | 10 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Apr 21, 2011 | clinicaltrials |
| NCT01249690 | Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma | unknown | Phase 4 | 100 | Second Military Medical UniversityOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00846703 | The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia | unknown | Phase 4 | 600 | Sun Yat-sen UniversityOTHER | 1 | Mar 8, 2010 | clinicaltrials |
| NCT00222612 | Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003 | unknown | Phase 4 | 2,100 | University of OxfordOTHER | 1 | Feb 3, 2010 | clinicaltrials |
| NCT00192673 | Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses | unknown | Phase 4 | 85 | Nordic Society for Pediatric Hematology and OncologyOTHER | 1 | Sep 30, 2009 | clinicaltrials |
| NCT00797810 | Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults | unknown | Phase 4 | 25 | University of BolognaOTHER | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00838019 | Intrabone Cord Blood Transplantation | unknown | Phase 4 | 10 | Hospital Clinic of BarcelonaOTHER | 1 | Feb 6, 2009 | clinicaltrials |
| NCT00196768 | Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic | unknown | Phase 4 | 30 | German AML Cooperative GroupOTHER | 1 | Oct 23, 2007 | clinicaltrials |
| NCT00188149 | Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET | unknown | Phase 4 | 300 | University Hospital Carl Gustav CarusOTHER | 1 | Dec 29, 2005 | clinicaltrials |
| NCT00199147 | Efficacy of G-CSF-Priming in Elderly AML Patients | unknown | Phase 4 | 250 | Johann Wolfgang Goethe University HospitalOTHER | 1 | Oct 26, 2005 | clinicaltrials |
| NCT00131313 | Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. | unknown | Phase 4 | 180 | East Valley Hematology and Oncology Medical GroupOTHER | 1 | Aug 18, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Dec 21, 2016source: clinicaltrials